Vimarsana
Biggest News Aggregation in the World

Page 39 - Practice Guidelines News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Practice Guidelines. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Practice Guidelines Today - Breaking & Trending Today

Philippine Nurses Association President Melvin Miranda brings knowledge, expertise to MCU's nursing program - Vimarsana News

Philippine Nurses Association President Melvin Miranda brings knowledge, expertise to MCU's nursing program

Among the key players in the nursing industry is Manila Central University (MCU), one of the oldest universities in the Philippines. But how does it keep itself relevant today, and make itself a top and competitive player in the nursing industry?

Genmab Announces Epcoritamab Added to National Comprehensive Cancer Network® (NCCN®) Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for 'B-Cell Lymphomas' - Vimarsana News

Genmab Announces Epcoritamab Added to National Comprehensive Cancer Network® (NCCN®) Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for 'B-Cell Lymphomas'

Genmab A/S (Nasdaq: GMAB) today announced that epcoritamab, a T-cell engaging bispecific antibody, has been added to the National Comprehensive Cancer Network® (NCCN®) Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for “B-c...

Optimizing Treatment Patterns in Relapsed or Refractory Differentiated Thyroid Cancer - Vimarsana News

Optimizing Treatment Patterns in Relapsed or Refractory Differentiated Thyroid Cancer

A panel of head and neck cancer experts discussed the nuances of managing relapsed or refractory DTC with lenvatinib or sorafenib, as well as sequencing considerations with targeted therapies in the second-line setting and beyond for patients with relapsed or refractory disease.

Determining the Optimal Use of Adjuvant Immunotherapy in Renal Cell Carcinoma - Vimarsana News

Determining the Optimal Use of Adjuvant Immunotherapy in Renal Cell Carcinoma

Kidney and renal pelvis cancers are one of the 10 most common new malignant diagnoses in both men and women in the United States, with an estimated 52,360 new cases in men and 29,440 new cases in women per year.

Healthtech Creates Investment Opportunities in India's Healthcare Industry - Vimarsana News

Healthtech Creates Investment Opportunities in India's Healthcare Industry

COVID-19 is reshaping India's healthcare landscape with various segments, including healthtech and telehealth, nutrition, and hygiene primed for innovation.